South Korea Sequential Compression Device Market Size, Production, Sales, Average Product Price, Market Share 

South Korea Sequential Compression Device Market Revenue Size and Production Analysis 

South Korea Sequential Compression Device Market Size is expected to grow at an impressive rate during the next seven years. 

 Surge in Surgical Procedures Boosting Compression Device Demand 

The South Korea Sequential Compression Device market is steadily expanding, driven by increased surgical volumes and heightened awareness of post-operative care standards. With over 4.5 million surgical procedures conducted annually across South Korea’s advanced healthcare infrastructure, there is growing pressure on hospitals to mitigate post-operative complications such as deep vein thrombosis (DVT) and pulmonary embolism. As a result, Sequential Compression Devices (SCDs) have become a key preventive tool, offering non-invasive mechanical prophylaxis to reduce clotting risks during patient immobility. 

Major medical centers in Seoul, Busan, Incheon, and Daegu have already integrated SCDs into their routine surgical recovery workflows. These institutions, often affiliated with leading universities and national health bodies, are shaping clinical practice trends by standardizing recovery protocols that include compression therapy. The South Korea Sequential Compression Device market has benefited significantly from this institutional leadership, which has encouraged a trickle-down effect across secondary hospitals, rehabilitation centers, and private surgical clinics. 

Hospital administrators are increasingly prioritizing outcome-based care, which directly supports wider adoption of SCDs. Shorter hospital stays, lower readmission rates, and reduced use of anticoagulants are among the metrics driving device purchases. The integration of SCDs into Enhanced Recovery After Surgery (ERAS) programs further reinforces their value, particularly in orthopedic and gynecological surgeries. This growing institutional emphasis on risk prevention and recovery optimization continues to push demand within the South Korea Sequential Compression Device market. 

Aging Population and Chronic Illness Increasing Device Utilization 

South Korea’s rapidly aging population is one of the primary drivers of the South Korea Sequential Compression Device market. As of 2024, over 18% of South Korea’s population is aged 65 and above, a figure expected to approach 25% by 2035. Older patients are more likely to require joint replacements, cardiovascular surgeries, and cancer interventions, all of which carry high risk for thrombotic events due to prolonged immobilization. Hospitals are proactively responding to this demographic shift by expanding their use of compression therapy in geriatric care units and surgical wards. 

The increasing prevalence of non-communicable diseases is also influencing the demand for Sequential Compression Device in South Korea. Conditions such as cancer, obesity, diabetes, and heart disease are driving more surgical interventions and inpatient treatments, which in turn heighten the risk of clot formation. Clinicians across the country are incorporating mechanical thromboprophylaxis into treatment plans for high-risk patients, particularly when pharmacological alternatives are contraindicated. As a result, the South Korea Sequential Compression Device market is expanding its footprint across multiple departments including oncology, cardiology, and internal medicine. 

Rehabilitation medicine is another segment driving SCD adoption. Many post-operative and stroke patients require long periods of limited mobility, and compression therapy is now recognized as a safe and effective measure for improving circulation during recovery. As physiotherapy departments adopt more comprehensive approaches to recovery, the inclusion of SCDs is becoming a standard element. This cross-disciplinary utility contributes to consistent procurement patterns and strengthens the long-term outlook of the South Korea Sequential Compression Device market. 

Procurement Trends and Regional Market Diversification 

Hospitals in South Korea employ a highly organized and data-driven procurement process, which is helping streamline equipment acquisition in favor of clinical outcome-based investments. Large hospital systems and public university medical centers typically procure SCDs through annual tenders or capital budgeting processes, focusing on product durability, service track record, and clinical validation. Meanwhile, private hospitals and surgical chains often operate under more flexible procurement models, emphasizing turnaround time, maintenance support, and compatibility with existing hospital systems. These dual procurement pathways sustain balanced demand in the South Korea Sequential Compression Device market. 

Regionally, the market is no longer concentrated solely in metropolitan cities. Hospitals in smaller provinces such as Gangwon, North Gyeongsang, and South Jeolla are investing in surgical upgrades and post-operative care enhancements. These hospitals are increasingly adopting SCDs in line with national guidelines on thrombosis prevention. Suppliers targeting these secondary markets are finding success by offering mid-range devices, bundled service packages, and localized training programs. This regional diversification is a key characteristic of the South Korea Sequential Compression Device market and offers long-term stability against saturation in urban hubs. 

In addition to hospitals, rehabilitation clinics and long-term care centers are beginning to show interest in SCDs. These facilities tend to prioritize devices that are portable, easy to operate, and energy-efficient. Suppliers that offer scalable product lines with low maintenance needs are better positioned to enter this evolving segment. Furthermore, national reimbursement models that support preventive care are also influencing equipment budgets and increasing purchasing flexibility, thereby creating new entry points for vendors in the South Korea Sequential Compression Device market. 

Product Differentiation, Technological Innovation, and Education Strategy 

Technological innovation is becoming a significant differentiator in the South Korea Sequential Compression Device market. Hospitals are increasingly seeking devices with enhanced monitoring features, programmable pressure settings, and seamless integration into digital hospital infrastructure. High-end models offering silent operation, automated alerts, and compliance tracking are in demand among larger institutions that prioritize patient safety and workflow efficiency. These capabilities also support nursing staff by reducing manual oversight and providing better patient adherence data. 

Education and training are equally vital to sustained market expansion. Despite the increasing familiarity with SCDs among surgeons and ICU specialists, many general medical staff and nurses require refresher courses to ensure proper usage. Manufacturers and distributors that provide on-site training, virtual education platforms, and multilingual user materials are gaining preference among hospitals. This emphasis on clinician education also improves device utilization rates and encourages repeat procurement, reinforcing the vendor’s role as a partner rather than just a product supplier in the South Korea Sequential Compression Device market. 

The demand for Sequential Compression Device in South Korea is also being supported by bundled service models. These include device leasing programs, long-term service agreements, and performance-based contracts. Hospitals facing budget constraints are finding value in subscription-based solutions that provide the latest technology without the burden of large capital expenditures. This shift toward service-oriented procurement reflects broader trends in South Korea’s medical technology sector and is expected to play an increasingly important role in shaping how the South Korea Sequential Compression Device market evolves. 

Growth Forecast, Policy Environment, and Strategic Investment Pathways 

The South Korea Sequential Compression Device market is projected to grow at a compound annual growth rate of 6% to 8% through 2030. This growth is supported by government initiatives to improve surgical care quality, aging population dynamics, and technological innovation in post-operative equipment. National medical guidelines continue to reinforce the importance of thromboembolism prevention, and SCDs are now embedded in most procedural protocols involving high-risk patients. The result is a steady increase in hospital budgets allocated for mechanical prophylaxis tools across the healthcare system. 

The long-term outlook for the South Korea Sequential Compression Device market is also shaped by favorable reimbursement conditions and a robust regulatory environment. Medical devices that demonstrate clear clinical efficacy are generally eligible for inclusion in hospital reimbursement schemes. This reduces the financial barrier for hospitals and facilitates faster adoption. Manufacturers that engage early with regulatory bodies and invest in localized clinical studies will benefit from smoother product approvals and stronger credibility in competitive tenders. 

From a strategic standpoint, companies looking to expand in the South Korea Sequential Compression Device market should consider hybrid models that combine premium product offerings with accessible mid-range systems. Local partnerships with distributors, clinical training institutes, and hospital networks are critical for scaling operations and enhancing customer retention. Additionally, investing in smart technologies—such as connected SCDs with real-time usage tracking and remote monitoring—can appeal to digital-first institutions looking for long-term efficiency. 

In conclusion, the South Korea Sequential Compression Device market presents a dynamic and growing opportunity for medical technology firms that understand the country’s clinical priorities, regulatory expectations, and operational frameworks. As hospitals pursue safer, faster, and more cost-effective recovery protocols, the use of SCDs will become increasingly embedded in everyday care. Companies that combine innovation, education, and service excellence will be well-positioned to lead in this expanding and strategically important medical device market. 

South Korea Sequential Compression Device (SCD) Market: Innovating Preventive Therapy, Strengthening Surgical Outcomes & Advancing Smart Medical Technology (2023–2035) 

 

1. Executive Summary and Market Overview 

• Snapshot of the SCD Market in South Korea 

• Role of Compression Devices in Enhancing Clinical Safety and Outcomes 

• Key Trends, Market Dynamics, and Future Growth Forecast 

 

2. Public Health Vision and Strategic Alignment 

• Integration of SCDs With South Korea’s Digital Health and UHC Goals 

• Alignment With National Health Promotion and Aging Society Policies 

• Relevance to Korea Disease Control and Prevention Agency (KDCA) Directives 

 

3. Study Scope, Objectives, and Research Methodology 

• Market Scope and Segmentation by Device, Care Setting, and Use Case 

• Research Framework, Data Sources, and Analytical Tools 

• Forecasting Models and Assumptions Through 2035 

 

4. Therapeutic Role and Clinical Value of SCDs 

• SCD Use in Preventing DVT and PE Among Surgical and Immobilized Patients 

• Applications in Orthopedic, Cardiac, Oncology, and ICU Care 

• Contribution to Enhanced Recovery Protocols and Inpatient Safety Standards 

 

5. Healthcare System Structure and Care Delivery Ecosystem 

• Overview of the National Health Insurance System (NHIS) 

• Roles of Tertiary Hospitals, Public Clinics, and Private Institutions 

• Referral Mechanisms, Patient Flow, and Postoperative Care Access 

 

6. Epidemiological Drivers and Demand Trends 

• Aging Population and Rise in Chronic Diseases Requiring Surgical Intervention 

• National Surgery Volume and ICU Admission Patterns 

• Regional Disease Burden Influencing Compression Therapy Adoption 

 

7. Technology Landscape and Product Typologies 

• Classification of SCDs: Pneumatic, Portable, Smart, and Reusable 

• Trends in IoT-Enabled Devices, Compliance Monitoring, and Wearable Formats 

• Innovation in Patient-Centric Design and Energy Efficiency 

 

8. Regulatory Environment and Market Entry Pathways 

• Medical Device Regulations Under the Ministry of Food and Drug Safety (MFDS) 

• Approval Process, Import Registration, and Compliance with K-GMP Standards 

• Harmonization With Global Certification (FDA, CE) and Local Testing Requirements 

 

9. Procurement and Supply Mechanisms 

• Hospital-Level Equipment Acquisition and Group Purchasing Organizations (GPOs) 

• Government Procurement Through Public Procurement Service (PPS) 

• Leasing, Vendor-Managed Inventory, and Reimbursement-Linked Purchasing 

 

10. Health Insurance and Reimbursement Framework 

• National Health Insurance Coverage for SCDs in Inpatient and Surgical Care 

• Reimbursement Classifications and Impact on Device Uptake 

• Role of Private Insurers and Supplemental Health Plans 

 

11. Facility Readiness and Infrastructure Penetration 

• SCD Deployment in Major Tertiary Centers (e.g., Samsung Medical Center, Asan Hospital) 

• Device Availability in Community and Long-Term Care Facilities 

• Operational Integration in ICUs, ORs, and Surgical Wards 

 

12. Clinical Workforce and Training Ecosystem 

• Training Needs Among Nursing Staff, Surgeons, and Technicians 

• Inclusion in Continuing Medical Education (CME) and Residency Curricula 

• Gaps in Usage Protocols and Institutional SOPs for SCDs 

 

13. Import Channels, Distribution, and Logistics 

• Key Import Points: Busan Port, Incheon Airport, and Seoul Distribution Hubs 

• Local Distributors, Sales Agents, and National Medical Device Suppliers 

• Cold Chain Logistics, Maintenance Support, and After-Sales Services 

 

14. Regional Distribution and Access Equity 

• Device Utilization Trends Across Seoul, Gyeonggi, and Regional Provinces 

• Access Challenges in Remote or Low-Volume Surgical Centers 

• Policy Tools to Support Equitable Device Allocation 

 

15. Patient Awareness and Engagement Models 

• Understanding of SCD Function Among Patients and Caregivers 

• Health Literacy Programs and Informed Consent Processes 

• Role of Mobile Health Apps in Educating and Monitoring Post-Surgical Patients 

 

16. Environmental Considerations and Sustainability Goals 

• Device Lifespan, Reuse Protocols, and Hospital Waste Management Practices 

• Eco-Friendly Procurement Initiatives in Green Hospitals 

• Circular Economy Opportunities in Component Refurbishment 

 

17. Smart Health Integration and Digital Infrastructure 

• Smart Compression Devices With Real-Time Monitoring and Data Sharing 

• Integration With Korea’s Electronic Medical Record (EMR) Platforms 

• Role of AI, IoT, and Remote Care in Enhancing SCD Efficiency 

 

18. Global Collaboration and Innovation Ecosystem 

• Partnerships With International OEMs and Joint Ventures With Korean Firms 

• Role of the Korea Health Industry Development Institute (KHIDI) 

• Government Support for MedTech Startups and R&D Commercialization 

 

19. Market Size and Forecast Outlook (2023–2035) 

• National SCD Demand Projections by Segment and Clinical Setting 

• Public vs. Private Sector Uptake and Regional Growth Trends 

• Scenario Modeling: Baseline, Policy-Accelerated, and Innovation-Led Growth 

 

20. Competitive Landscape and Industry Dynamics 

• Key International and Domestic Players in South Korea’s SCD Market 

• Market Share by Device Type, Service Model, and Distribution Network 

• Competitive Strategies: Localization, Technical Support, and Warranty Offerings 

 

21. Market Barriers and Strategic Risks 

• Regulatory and Pricing Delays, Hospital Budget Constraints 

• Clinical Practice Variation and Resistance to Device Adoption 

• Supply Chain Disruptions and Import Dependency Risks 

 

22. Use Cases and Institutional Success Stories 

• SCD Implementation at Seoul National University Hospital and Yonsei Severance 

• Pilots in Provincial Hospitals and Post-Acute Care Facilities 

• Clinical Outcomes and Process Improvements Through Device Deployment 

 

23. Recommendations for Policy and Market Development 

• Enhancing Coverage, Speeding Approvals, and Encouraging Local Innovation 

• Expanding Training and Awareness Among Clinicians and Administrators 

• Supporting Cross-Sector Partnerships for Inclusive Device Access 

 

24. South Korea 2035: Vision for a Resilient SCD Ecosystem 

• Digital, Sustainable, and Preventive Healthcare Through SCD Integration 

• Local Innovation, Global Partnerships, and Smart Infrastructure 

• A Future-Ready Framework for Improving Surgical Recovery and Patient Safety 

 

  

  

About South Korea Demography:

South Korea Sequential Compression Device market analysis, production, capacity, average price, market share, top market trends, import vs export  

South Korea Sequential Compression Device Market Size, Production, Price, Market Share, Import vs Export, and Top Latest Trends, till 2035